For the interest and benefit of ESCP members, the Research Committee are going to write a monthly short report on a significant colorectal article that has been published in the last six months.
These summaries should provide an informative read on significant developments that have the potential to help patients. We would welcome your suggestions regarding articles and also your ideas on how this initiative may be developed.
On 10 Mar 2023
March’s paper of the month looks at the FOxTROT trial, a randomised control trial comparing recurrence rate in patients with locally advanced colon cancer receiving neoadjuvant chemotherapy (NAC) vs. postoperative chemotherapy.On 16 Feb 2023
February's paper of the month looks at the treatment of patients with metastastic colorectal cancer patients with BRAFV600E mutations.On 1 Nov 2022
November's Paper of the Month looks at the Efficacy and safety of extended duration to perioperative thromboprophylaxisOn 5 Sep 2022
September’s paper of the month looks at the FORCE trial, a randomized control trial aiming to improve the intestinal function (LARS score) and the quality of life (QoL) of patients who had undergone a low anterior resection for rectal cancer.On 8 Aug 2022
August's paper of the month looks at the effect of circulating tumor DNA analysis as a guide for adjuvant therapy in Stage II Colon Cancer.Page 4 of 12
ESCP Secretariat
c/o Lindsays
Caledonian Exchange
19a Canning Street
Edinburgh EH3 8HE
United Kingdom
